IL5RA and nasal cavity polyp: The occurrence of nasal polyps and mucosal oedema in intranasal inspection was significantly reduced in the anti-IL5/IL5R group (p = 0.038 and p = 0.004 respectively) but not in the anti-IgE group (Table 5).